That sounds impossible.
Most people grow up believing heart disease is simple:
- High cholesterol is bad.
- Low cholesterol is good.
- Normal cholesterol means low risk.
And to a degree, that is true.
LDL
Low-density lipoprotein cholesterol, or LDL cholesterol, is what most people have heard referred to as "bad cholesterol."
LDL particles carry cholesterol through the bloodstream to tissues throughout the body.
Higher circulating LDL levels are associated with greater cholesterol deposition inside artery walls over time. Decades of research have shown that elevated LDL plays a major role in atherosclerosis, the process underlying most heart attacks and many strokes.
In general, the higher the LDL exposure over a lifetime, the greater the cardiovascular risk.
That is why lowering LDL remains one of the cornerstones of preventive cardiology.
But LDL is not the entire story.
HDL
High-density lipoprotein cholesterol, or HDL cholesterol, is what most people know as "good cholesterol."
HDL particles help transport cholesterol back toward the liver for processing and removal.
For years, many patients were told some version of:
"Your bad cholesterol is elevated, but your good cholesterol is high too, so that protects you."
And historically, higher HDL levels were associated with lower cardiovascular risk in large population studies.
But more recent research has complicated that story.
Raising HDL itself does not necessarily reduce cardiovascular risk. Multiple medications that successfully raised HDL failed to improve cardiovascular outcomes.
In other words, HDL appears to function more as a marker associated with metabolic health than as a direct protective force capable of fully offsetting elevated cardiovascular risk.
A patient can therefore have high HDL, "normal" LDL, and still carry substantial cardiovascular risk because of other underlying factors.
That realization changed preventive cardiology significantly.
Because it suggested cardiovascular risk could not be understood by looking at LDL cholesterol alone.
What a standard panel misses
- inflammation
- insulin resistance
- genetics
- particle number
- metabolic health
- smoking
- blood pressure
- visceral fat accumulation
- family history
Triglycerides
Triglycerides are another important piece of the puzzle.
Triglycerides are a form of circulating fat used for energy storage.
Elevated triglycerides can be one of the earliest clues that insulin resistance or metabolic dysfunction is developing, sometimes years before blood sugar levels formally become abnormal.
A patient may technically have:
- "normal" cholesterol
- acceptable LDL levels
- even high HDL levels
while simultaneously developing:
- insulin resistance
- chronic inflammation
- metabolic syndrome
- visceral fat accumulation
- elevated cardiovascular risk
This is one reason cardiovascular risk cannot always be understood through cholesterol numbers alone.
Atherosclerosis
Your body actually needs cholesterol. Cholesterol is essential for hormone production, vitamin D synthesis, cell membranes, and brain function.
The problem is not cholesterol existing in the bloodstream.
The problem is what happens when cholesterol-carrying particles repeatedly enter and become trapped inside the walls of arteries over years and decades.
Once trapped, they trigger inflammation.
The immune system responds.
Plaque begins to form.
Over time, that plaque can harden, grow, rupture, restrict blood flow, or trigger clot formation.
That process is called atherosclerosis.
And it is the process underlying most heart attacks and many strokes.
Heart disease is not simply a problem of "too much fat."
It is a chronic inflammatory disease occurring inside the walls of arteries.
ApoB
A standard LDL cholesterol result does not actually measure how many cholesterol-carrying particles are moving through the bloodstream.
It measures how much cholesterol is contained inside them.
That distinction matters.
Imagine two patients with exactly the same LDL cholesterol level.
One patient may have relatively few particles carrying larger amounts of cholesterol.
The other may have a very large number of smaller particles.
Even though the LDL cholesterol level looks identical on paper, the second patient's arteries are being exposed to far more particle collisions over time.
More particles create more opportunities for particles to enter the arterial wall.
And more opportunities for inflammation and plaque formation.
This is one reason some patients with "normal cholesterol" still develop cardiovascular disease.
This is where ApoB becomes important.
ApoB stands for apolipoprotein B.
It is a protein found on the surface of nearly every particle capable of contributing to plaque formation.
Importantly, each LDL particle carries one ApoB molecule.
That means ApoB functions as an approximate count of the total number of potentially plaque-forming particles circulating through the bloodstream.
A patient can therefore have normal LDL cholesterol, very high ApoB, and significantly elevated cardiovascular risk, all at the same time.
In these patients, LDL cholesterol alone may substantially underestimate cardiovascular risk.
Many preventive cardiologists now consider ApoB one of the most useful markers for understanding long-term cardiovascular risk.
Lipoprotein(a)
Another important marker is lipoprotein(a), usually written as Lp(a).
Lp(a) is a genetically inherited cholesterol-carrying particle associated with accelerated plaque formation and increased clotting risk.
Elevated Lp(a) is associated with:
- premature heart disease
- heart attack
- stroke
- calcific aortic stenosis
Importantly, lifestyle changes have relatively little effect on Lp(a).
A patient can eat extremely well, exercise consistently, maintain a healthy weight, and still carry substantially elevated cardiovascular risk because of inherited Lp(a).
Insulin Resistance
Cardiovascular disease is not only about cholesterol.
Insulin resistance can begin years before fasting glucose or hemoglobin A1c formally become abnormal.
Insulin resistance means the body is becoming less responsive to insulin, forcing the pancreas to produce progressively larger amounts to maintain normal blood sugar levels.
During that process, metabolic dysfunction may already be contributing to:
- chronic inflammation
- elevated triglycerides
- low HDL cholesterol
- hypertension
- increased small dense LDL particles
- visceral fat accumulation
- accelerated plaque formation
A fasting glucose of 92 may technically be "normal" while substantial metabolic dysfunction is already underway.
Family History
A patient with a strong family history of early cardiovascular disease should not automatically be reassured by a standard lipid panel alone.
Family history often reflects inherited inflammatory patterns, metabolic tendencies, lipoprotein abnormalities, or genetic cardiovascular risk factors that standard testing may not fully capture.
When a parent or sibling develops premature cardiovascular disease despite appearing otherwise healthy, that history deserves attention.
Coronary Calcium Scoring
In selected patients, coronary artery calcium scoring, often shortened to CAC scoring, can provide additional information about actual plaque burden rather than estimated risk alone.
A CAC scan does not replace thoughtful metabolic evaluation, but it can sometimes help clarify whether long-term cardiovascular risk is already translating into measurable arterial disease.
The Bigger Picture
Advanced cardiovascular testing is not about creating fear or turning healthy people into patients.
It is about recognizing that cardiovascular disease develops gradually over decades, often long before a standard cholesterol panel becomes obviously abnormal.
Real prevention requires asking not only whether disease is present today, but whether the physiologic patterns associated with future disease are already beginning to emerge.
Because "normal" is not always the same thing as low risk.
← Back to Journal